Skopos Labs, Inc. Pacira Bio Sciences, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 2,238 shares of PCRX stock, worth $58,725. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,238
Previous 474
372.15%
Holding current value
$58,725
Previous $8,000
587.5%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$210 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$138 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$59.4 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$58.8 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$53.8 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.2B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...